159 related articles for article (PubMed ID: 21747684)
1. Study on the expression and clinical significances of lewis y antigen and integrin αv, β3 in epithelial ovarian tumors.
Wang Y; Liu J; Lin B; Wang C; Li Q; Liu S; Yan L; Zhang S; Iwamori M
Int J Mol Sci; 2011; 12(6):3409-21. PubMed ID: 21747684
[TBL] [Abstract][Full Text] [Related]
2. Expression of Lewis y antigen and integrin αv, β3 in ovarian cancer and their relationship with chemotherapeutic drug resistance.
Gao J; Hu Z; Liu D; Liu J; Liu C; Hou R; Gao S; Zhang D; Zhang S; Lin B
J Exp Clin Cancer Res; 2013 Jun; 32(1):36. PubMed ID: 23725446
[TBL] [Abstract][Full Text] [Related]
3. Expression and correlation of Lewis y antigen and TGF-β1 in ovarian epithelial carcinoma.
Wang ST; Liu JJ; Wang CZ; Lin B; Hao YY; Wang YF; Gao S; Qi Y; Zhang SL; Iwamori M
Oncol Rep; 2012 Apr; 27(4):1065-71. PubMed ID: 22138668
[TBL] [Abstract][Full Text] [Related]
4. Co-expression of Lewis y antigen with human epididymis protein 4 in ovarian epithelial carcinoma.
Zhuang H; Gao J; Hu Z; Liu J; Liu D; Lin B
PLoS One; 2013; 8(7):e68994. PubMed ID: 23894390
[TBL] [Abstract][Full Text] [Related]
5. The stimulation of IGF-1R expression by Lewis(y) antigen provides a powerful development mechanism of epithelial ovarian carcinoma.
Liu D; Liu J; Wang C; Lin B; Liu Q; Hao Y; Zhang S; Iwamori M
Int J Mol Sci; 2011; 12(10):6781-95. PubMed ID: 22072919
[TBL] [Abstract][Full Text] [Related]
6. Lewis(y) antigen promotes the progression of epithelial ovarian cancer by stimulating MUC1 expression.
Hou R; Jiang L; Liu D; Lin B; Hu Z; Gao J; Zhang D; Zhang S; Iwamori M
Int J Mol Med; 2017 Aug; 40(2):293-302. PubMed ID: 28586014
[TBL] [Abstract][Full Text] [Related]
7. Chemoresistance is associated with MUC1 and Lewis y antigen expression in ovarian epithelial cancers.
Zhang D; Gao J; Zhu L; Hu Z; Hou R; Liu S; Tan M; Liu J; Lin B
Int J Mol Sci; 2013 May; 14(6):11024-33. PubMed ID: 23708102
[TBL] [Abstract][Full Text] [Related]
8. [Immunohistochemical expression of integrin alphav, beta5 and beta3 in ovarian epithelial carcinoma: correlation with drug resistance of chemotherapy].
Guo HY; Han JS; Zhang LF; Wang LN; Geng L; Chen GA
Zhonghua Fu Chan Ke Za Zhi; 2004 Nov; 39(11):750-3. PubMed ID: 15634501
[TBL] [Abstract][Full Text] [Related]
9. The expression of annexin II and Lewis y antigen in ovarian epithelial tumors and the correlation between them.
Zhuang H; Tan M; Liu J; Li X; Gao J; Hu Z; Deng L; Zhu L; Lin B
Tumour Biol; 2015 Apr; 36(4):2343-9. PubMed ID: 25416440
[TBL] [Abstract][Full Text] [Related]
10. Expression and correlation of Lewis y antigen and integrins α5 and β1 in ovarian serous and mucinous carcinoma.
Li Q; Liu S; Lin B; Yan L; Wang Y; Wang C; Zhang S
Int J Gynecol Cancer; 2010 Dec; 20(9):1482-9. PubMed ID: 21119363
[TBL] [Abstract][Full Text] [Related]
11. Integrins and haptoglobin: Molecules overexpressed in ovarian cancer.
Villegas-Pineda JC; Garibay-Cerdenares OL; Hernández-Ramírez VI; Gallardo-Rincón D; Cantú de León D; Pérez-Montiel-Gómez MD; Talamás-Rohana P
Pathol Res Pract; 2015 Dec; 211(12):973-81. PubMed ID: 26549463
[TBL] [Abstract][Full Text] [Related]
12. High expressions of BCL6 and Lewis y antigen are correlated with high tumor burden and poor prognosis in epithelial ovarian cancer.
Zhu L; Feng H; Jin S; Tan M; Gao S; Zhuang H; Hu Z; Wang H; Song Z; Lin B
Tumour Biol; 2017 Jul; 39(7):1010428317711655. PubMed ID: 28671040
[TBL] [Abstract][Full Text] [Related]
13. Expression of CD147 and Lewis y antigen in ovarian cancer and their relationship to drug resistance.
Gao J; Hu Z; Liu J; Liu D; Wang Y; Cai M; Zhang D; Tan M; Lin B
Med Oncol; 2014 May; 31(5):920. PubMed ID: 24692145
[TBL] [Abstract][Full Text] [Related]
14. [Expression and promotor methylation of p73 gene in ovarian epithelial tumors].
Zhang YL; Guo XR; Shen DH; Cheng YX; Liang XD; Chen YX; Wang Y
Zhonghua Bing Li Xue Za Zhi; 2012 Jan; 41(1):33-8. PubMed ID: 22455848
[TBL] [Abstract][Full Text] [Related]
15. Collagen triple helix repeat containing 1 (CTHRC1) activates Integrin β3/FAK signaling and promotes metastasis in ovarian cancer.
Guo B; Yan H; Li L; Yin K; Ji F; Zhang S
J Ovarian Res; 2017 Oct; 10(1):69. PubMed ID: 29021002
[TBL] [Abstract][Full Text] [Related]
16. Elevated levels of Lewis y and integrin α5β1 correlate with chemotherapeutic drug resistance in epithelial ovarian carcinoma.
Hu Z; Gao S; Gao J; Hou R; Liu C; Liu J; Li B; Liu D; Zhang S; Lin B
Int J Mol Sci; 2012 Nov; 13(12):15588-600. PubMed ID: 23443083
[TBL] [Abstract][Full Text] [Related]
17. AlphaV- and beta1-integrin subunits are commonly expressed in malignant effusions from ovarian carcinoma patients.
Davidson B; Goldberg I; Reich R; Tell L; Dong HP; Trope' CG; Risberg B; Kopolovic J
Gynecol Oncol; 2003 Aug; 90(2):248-57. PubMed ID: 12893184
[TBL] [Abstract][Full Text] [Related]
18. The immunohistochemical expression of p53 and Ki67 in ovarian epithelial borderline tumors. Correlation with clinicopathological factors.
Giurgea LN; Ungureanu C; Mihailovici MS
Rom J Morphol Embryol; 2012; 53(4):967-73. PubMed ID: 23303020
[TBL] [Abstract][Full Text] [Related]
19. High expression of Lewis y antigen and CD44 is correlated with resistance to chemotherapy in epithelial ovarian cancers.
Hu Z; Gao J; Zhang D; Liu Q; Yan L; Gao L; Liu J; Liu D; Zhang S; Lin B
PLoS One; 2013; 8(2):e57250. PubMed ID: 23468946
[TBL] [Abstract][Full Text] [Related]
20. Co‑expression of Lewis y antigen and CD147 in epithelial ovarian cancer is correlated with malignant progression and poor prognosis.
Liu J; Liu Q; Wang Y; Liu M; Qi Y; Gao J; Lin B
Int J Mol Med; 2019 Apr; 43(4):1687-1698. PubMed ID: 30816446
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
